Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H29N3O3 |
Molar mass | 419.525 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Adimolol (developmental code name MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.[1]
Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
---|---|---|---|---|---|
Other antagonists |
| ||||
|
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||